Document:DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021: Difference between revisions
From GxPlex
Gxplex admin (talk | contribs) m 1 revision imported |
gxplex>GxPlexBot Import from GxPlex Excel |
||
| Line 36: | Line 36: | ||
<noinclude> | <noinclude> | ||
== References == | == References == | ||
{| class="wikitable | {| class="wikitable" | ||
! Reference !! Scope !! Document part !! Language !! Preview | ! Reference !! Scope !! Document part !! Language !! Preview | ||
|- | |- | ||
Revision as of 15:06, 29 June 2026
| Document information | |
|---|---|
| Reference | DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4
04-Feb-2021 |
| Validity area | DEU |
| Scope(s) | G |
| Document name | Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 |
| Version / Revision | v4
04-Feb-2021 |
| Status | Current |
| Document type | Official recommendation |
| Language(s) | DE |
| Description | Ergänzende Empfehlungen des BfArM und des PEI zur Europäischen Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic, Version 4 |
| Official source | Official link |
| Restricted access | No |
| Submitted by | Florian Adragna |
| Contributors | |
References
| Reference | Scope | Document part | Language | Preview |
|---|---|---|---|---|
| Reference:DEU Empfehlungen des BfArM und des PEI zur Europäischen Guidance during COVID-19 v4 04-Feb-2021 - | G | - | DE | Ergänzende Empfehlungen des BfArM und des PEI zur Europäischen Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic […] Unabhängig von der gewählten Methode für ... |
